Ling Fu

900 citations

19 papers · 715 indexed · h-index 11

Impact in

Complementary and alternative medicine top 10%
Cancer Research
- Cancer, Hypoxia, and Metabolism

Papers in

Complementary and alternative medicine 7
- Natural Compounds in Disease Treatment 5
- Traditional Chinese Medicine Studies 2
Hematology 4
- Autoimmune and Inflammatory Disorders Research 3

Co-authors: Hans‐Peter Gerber Franklin Peale Xiumin Wu Wei‐Ching Liang Napoleone Ferrara Ajay K. Malik Y. Gloria Meng Germaine Fuh
Journals: Biomedicine & Pharmacotherapy (2 papers)Molecular Cancer Therapeutics (1 paper)International Journal of Environmental Research and Public Health (1 paper)Journal of Palliative Medicine (1 paper)The Journal of Pathology (1 paper)
Partner nations: China United States Australia

In The Last Decade

Ling Fu

18 papers receiving 673 citations

Peers

Countries citing papers authored by Ling Fu

Since Specialization

Citations

This map shows the geographic impact of Ling Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Fu more than expected).

Fields of papers citing papers by Ling Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Fu. The network helps show where Ling Fu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ling Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ling Fu Line = papers co-authored together Ling Fu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Efficacy of tripterygium glycosides (TG) in rheumatoid arthritis as a disease-modifying anti-rheumatic drug (DMARD) in combination with conventional DMARDs: A systematic review and meta-analysis of randomized controlled trials Pharmacological Research ·Zhe Feng, Ling Fu, Junqin Wang, فرناز فهیمی هنزایی, Mukhammad A. Abdurakhimov, Lingling Zhou, Xueping Zhou	2022	10
2	Protection of catalpol against triptolide-induced hepatotoxicity by inhibiting excessive autophagy via the PERK-ATF4-CHOP pathway PeerJ ·F Pedrazzi, Changqing Li, Ling Fu, Georgeta Făniţă, Gengrui Xu, Jie Zhou, Meiyu Shen, Zhe Feng, Huaxu Zhu, Tong Xie, Lingling Zhou, Xueping Zhou	2022	22
3	Effects of the Heart to Heart Card Game for Patients with Advanced Cancer Receiving Home-Based Palliative Care: A Clinical Randomized Controlled Trial International Journal of Environmental Research and Public Health ·Zh.A. Abalyan, Ling Fu, Daniel NM Sundaram, 修野手, 政明田中, Luisa Bartram, Xianmei Meng, Liping Yu	2022	5
4	Qingluotongbi formula regulates the LXRα-ERS-SREBP-1c pathway in hepatocytes to alleviate the liver injury caused by Tripterygium wilfordii Hook. f. Journal of Ethnopharmacology ·Georgeta Făniţă, Zhe Feng, Ling Fu, J. Denniston, Changqing Li, Huaxu Zhu, Tong Xie, Jie Zhou, Lingling Zhou, Xueping Zhou	2021	7
5	Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications Biomedicine & Pharmacotherapy ·Xian Zhou, Ling Fu, Pengli Wang, Lan Yang, Xiaoshu Zhu, Chun Guang Li	2021	48
6	Catalpol coordinately regulates phase I and II detoxification enzymes of Triptolide through CAR and NRF2 pathways to reduce Triptolide-induced hepatotoxicity Biomedicine & Pharmacotherapy ·Ling Fu, Lingling Zhou, Shan Geng, Ming Li, Wei Lü, Yan Lu, Zhe Feng, Xueping Zhou	2020	21
7	Meta‐Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis BioMed Research International ·Ming Li, Xueping Zhou, Lingling Zhou, Georgeta Făniţă, Ling Fu, Teresita Villamil-de Vásquez	2020	11
8	Efficacy and Safety of Integrated Traditional Chinese Medicine and Western Medicine on the Treatment of Rheumatoid Arthritis: A Meta‐Analysis Evidence-based Complementary and Alternative Medicine ·Ricardo Leon-Sampedro, Ling Fu, Georgeta Făniţă, Salter Fj	2020	39
9	Network Pharmacology-Based Prediction and Verification of Qingluo Tongbi Formula to Reduce Liver Toxicity of Tripterygium wilfordii via UGT2B7 in Endoplasmic Reticulum Medical Science Monitor ·Ming Li, J. Denniston, Ling Fu, Yan Lü, Jianya Xu, Lingling Zhou, Huaxu Zhu, Liang Fang, Zhe Feng, Tong Xie, Xueping Zhou	2020	6
10	The Effectiveness and Safety of Total Glucosides of Paeony in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis Frontiers in Pharmacology ·Zhe Feng, Imene Selka Oussadit, فرناز فهیمی هنزایی, Beibei Yu, Ling Fu, Lingling Zhou, Salter Fj, Yan Lu	2019	29
11	Exploring Palliative Care Competency Standards for Medical Education in China: A Survey of National Hospice Service Program Providers Journal of Palliative Medicine ·Jonathan Lio, Charlène Auregan, Lianlian Wu, Ling Fu, Renslow Sherer, He Li	2017	7
12	[Significance of clonal TCR gene rearrangement in acquired pure red cell aplastic anemia]. PubMed ·麻人浅木, An Li, N Kirova, Xiaoyan Zhang, Ling Fu, Xiaomin Wang	2016	1
13	Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models possibly through suppression of NF-κB activation Biochemical Pharmacology ·Paul Ndunelo, Xiangfang Tang, Xinghui Zhao, Minhong Zhang, Weijian Zhang, Shaohua Hou, Weifeng Yuan, Hongfu Zhang, Lijun Shi, Hong Peng Jia, Liang Lin, Azzedine Dekhane, C. T. Daltry, Keyu Zhang, Ling Fu, Wei Chen	2014	76
14	Interplay of neuropilin-1 and semaphorin 3A after partial hepatectomy in rats World Journal of Gastroenterology ·Ling Fu	2012	7
15	The Relationship Between Cancer Pain and Quality of Life in Patients Newly Admitted to Wuhan Hospice Center of China American Journal of Hospice and Palliative Medicine® ·Mark Aarons, Ling Fu, Yun Zhao, W. A. Smith, Amal N. Abdelrahman, Liang Chen, 万晓晓, Yun Zhou	2011	42
16	Abstract B153: A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamic (PD) activity of the dual PI3K/mTOR inhibitor GDC-0980 administered once weekly (QW). Molecular Cancer Therapeutics ·Antoine Hollebecque, Andrew R. Clamp, Laura Horsley, Jeffrey A. Morgan, Rastilav Bahleda, Suzanne George, Liza Rodriguez, Jennifer Lauchle, Joseph A. Ware, Rupal Desai, Jenny Wu, Ling Fu, Gordon C. Jayson, Jean‐Charles Soria, Andrew J. Wagner	2011	6
17	Plasmalemmal vesicle‐associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor‐A (VEGF) The Journal of Pathology ·Laura A Strickland, Adrian M. Jubb, Jo-Anne Hongo, Fiona Zhong, Ting Jiang, Ling Fu, Gretchen Frantz, Hartmut Koeppen	2005	96
18	Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF Journal of Biological Chemistry ·Wei‐Ching Liang, Xiumin Wu, Franklin Peale, Chingwei V. Lee, Y. Gloria Meng, Johnny Gutierrez, Ling Fu, Ajay K. Malik, Hans‐Peter Gerber, Napoleone Ferrara, Germaine Fuh	2005	282
19	Why our Western-trained doctors should learn traditional Chinese medicine. PubMed ·Ling Fu	2003	0

About Ling Fu

Ling Fu is a scholar working on Complementary and alternative medicine, Hematology, Developmental Neuroscience, Periodontics and Rheumatology, having authored 19 papers that have together received 715 indexed citations. Recurring topics across this work include Natural Compounds in Disease Treatment (5 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Palliative Care and End-of-Life Issues (3 papers), Natural product bioactivities and synthesis (2 papers), Patient Dignity and Privacy (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Traditional Chinese Medicine Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (69 citations), Cancer Research (114 citations), Pharmacology (58 citations), Anesthesiology and Pain Medicine (31 citations) and Molecular Biology (364 citations). Ling Fu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hans‐Peter Gerber, Franklin Peale, Xiumin Wu, Wei‐Ching Liang, Napoleone Ferrara, Ajay K. Malik, Y. Gloria Meng, Germaine Fuh, Chingwei V. Lee and Johnny Gutierrez. Their work appears in journals such as Biomedicine & Pharmacotherapy, Molecular Cancer Therapeutics, International Journal of Environmental Research and Public Health, Journal of Palliative Medicine and The Journal of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact